Drawing for CHI-MED HUTCHISON

USPTO serial 87092012

CHI-MED HUTCHISON

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KHAN, ASMAT A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHI-MED HUTCHISON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E. ABELMAN ABELMAN, FRAYNE & SCHWAB666 Third Avenue, 10th FloorNEW YORK, NY 10017-5621UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal, pharmaceutical and veterinary preparations for use in the treatment of cancer, gastrointestinal diseases, diseases affecting the internal organs and immune systems; digestive preparations for medical use; medicinal herbal preparations; herbal supplements; health food supplements; food additives for medicinal purposes; Chinese medicinal preparations for use in the treatment of cancer, cardiovascular diseases, colds and flu, gastrointestinal diseases, diseases affecting the internal organs, and immune systems; vitamin and mineral preparations for medical use and supplements; dietetic beverages adapted for medicinal purposes; baby food; infant food; medicinal oils; edible fish and algae oils for medical purposes, namely, fish oils, algae oil, cod liver oil, tuna oil, evening primrose oil, micro-encapsulated fish oils, emulsified fish oil, all for medical purposes, and nutritional substances for medical use, namely, nutritional supplements in capsule and tablet formACTIVE—
035Retail store services provided on-line from a computer database and the Internet and retail store services, all featuring medicinal and pharmaceutical preparations, digestive preparations, herbal preparations and supplements, Chinese medicines, vitamin and mineral preparations and supplements, dietetic substances, dietetic food and beverages adapted for medicinal purposes, biological and dietetic food preparations for medicinal purposes, health food supplements, and food additives for medicinal purposes, baby and infant food, medicinal oils, fish oils, cod liver oil, tuna oil, evening primrose oil, micro-encapsulated oils, emulsified oil, nutritional and dietetic substances in capsule or tablet form, all for medicinal purposes; advertising agency services; providing business information; promotion and marketing services; business management and advisory services, namely, assisting business in the formation of business plans and policies relating to medicine, personal health, diet and nutrition; business advisory and consultancy services; franchising services, namely, consultancy and assistance in business management, organization and promotion; Prescription services, namely, providing retail pharmacy servicesACTIVE—
042Medical research in the diagnosis and treatment of heart disease, skin conditions, bone disease, diabetes, cancer, memory loss, osteoporosis, arthritis, dementia, hepatitis, blood diseases, gastrointestinal diseases, diseases affecting the internal organs, nervous system, respiratory system and immune systems; providing specific medical and scientific research information in the field of pharmaceutical products, herbal preparations, Chinese medicines, dietetic substances, on-line and by the Internet to customers upon request; providing temporary use of non-downloadable software over the Internet for tracking documents and for providing information in the field of pharmaceutical products, herbal preparations, Chinese medicines, dietetic substancesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 9, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 9, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 14, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 13, 2019EX5GSOU EXTENSION 5 GRANTED—
Aug 13, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 7, 2019EXT5SOU EXTENSION 5 FILED—
Aug 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2019EX4GSOU EXTENSION 4 GRANTED—
Feb 7, 2019EXT4SOU EXTENSION 4 FILED—
Feb 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2018EX3GSOU EXTENSION 3 GRANTED—
Aug 7, 2018EXT3SOU EXTENSION 3 FILED—
Aug 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2018EX2GSOU EXTENSION 2 GRANTED—
Feb 7, 2018EXT2SOU EXTENSION 2 FILED—
Feb 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 9, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2017EX1GSOU EXTENSION 1 GRANTED—
Aug 7, 2017EXT1SOU EXTENSION 1 FILED—
Aug 7, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 9, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 3, 2016ALIEASSIGNED TO LIE—
Oct 19, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 19, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Oct 19, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 19, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 19, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 12, 2016DOCKASSIGNED TO EXAMINER—
Jul 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 6, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance